Hemodynamic Effects of Nisoldipine in Patients with Severe Chronic Congestive Heart Failure

[1]  R. Cody,et al.  Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure. , 1985, American heart journal.

[2]  J. Cohn,et al.  A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response. , 1985, American heart journal.

[3]  A. Ellrodt,et al.  Salutary hemodynamic and sustained clinical beneficial effects of nisoldipine, a new calcium channel blocker, in patients with recurrent ischemia and severe heart failure. , 1985, American heart journal.

[4]  P. Serruys,et al.  Acute effects of intravenous nisoldipine on left ventricular function and coronary hemodynamics. , 1985, The American journal of cardiology.

[5]  D. Conetta,et al.  Sublingual nifedipine: acute effects in severe chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy. , 1985, The American journal of cardiology.

[6]  M. Pfisterer,et al.  Important differences between short- and long-term hemodynamic effects of amiodarone in patients with chronic ischemic heart disease at rest and during ischemia-induced left ventricular dysfunction. , 1985, Journal of the American College of Cardiology.

[7]  O. Hess,et al.  Left ventricular function before and after diltiazem in patients with coronary artery disease. , 1985, Journal of the American College of Cardiology.

[8]  B. Lorell,et al.  Inotropic, vascular and neuroendocrine effects of nifedipine in heart failure: comparison with nitroprusside. , 1985, Journal of the American College of Cardiology.

[9]  Bramahn . Singh,et al.  Hemodynamic and metabolic effects of diltiazem during coronary sinus pacing with particular reference to left ventricular ejection fraction. , 1985, The American journal of cardiology.

[10]  B. Singh,et al.  Use of calcium antagonists in ventricular dysfunction. , 1985, The American journal of cardiology.

[11]  R. Magorien,et al.  Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow. , 1984, American heart journal.

[12]  L. Endrenyi,et al.  Effects of verapamil on [3H]norepinephrine release. , 1984, Journal of cardiovascular pharmacology.

[13]  R. Magorien,et al.  Beneficial effects of nifedipine on rest and exercise myocardial energetics in patients with congestive heart failure. , 1984, Circulation.

[14]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[15]  A. Timmis,et al.  Effects of vasodilator treatment with felodipine on haemodynamic responses to treadmill exercise in congestive heart failure. , 1984, British heart journal.

[16]  M. Wilén,et al.  Minoxidil in patients with chronic left heart failure: contrasting hemodynamic and clinical effects in a controlled trial. , 1984, Circulation.

[17]  B. Massie,et al.  Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses. , 1984, Circulation.

[18]  P. Ludbrook,et al.  The dependence of the cardiac effects of nifedipine on the responses of the peripheral vascular system. , 1984, Circulation.

[19]  D. Berman,et al.  Acute hemodynamic effect of oral nifedipine in severe chronic congestive heart failure. , 1983, The American journal of cardiology.

[20]  P. Erne,et al.  Hemodynamic and Reflex Responses to Acute and Chronic Antihypertensive Therapy with the Calcium Entry Blocker Nifedipine , 1983, Hypertension.

[21]  E. Kaplinsky,et al.  The Acute Hemodynamic Effects of Intravenous Verapamil in Coronary Artery Disease Assessment by Equilibrium-gated Radionuclide Ventriculography , 1983, Circulation.

[22]  J. Cohn,et al.  Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo. , 1982, American heart journal.

[23]  G. Ansalone,et al.  Oral Nifedipine in the Long‐Term Management of Severe Chronic Heart Failure , 1982, Journal of cardiovascular pharmacology.

[24]  M. Robinson.  Influence of severity of ventricular dysfunction on hemodynamic response to intravenously administered verapamil in ischemic heart disease: Chew CYC, Hecht HS, Collett JT, et al J Cardiol 47:917–922 Apr 1981 , 1982 .

[25]  J. Cohn,et al.  Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. , 1982, The American journal of cardiology.

[26]  G. Maxwell,et al.  Effect of Nisoldipine upon the General and Coronary Hemodynamics of the Anesthetized Dog , 1982, Journal of cardiovascular pharmacology.

[27]  R. Gorlin,et al.  Determinants of Drug Response in Severe Chronic Heart Failure. 1. Activation of Vasoconstrictor Forces During Vasodilator Therapy , 1981, Circulation.

[28]  S. Forsén,et al.  Interaction of the antihypertensive drug felodipine with calmodulin , 1981, Nature.

[29]  D. Warltier,et al.  Blood flow in normal and acutely ischemic myocardium after verapamil, diltiazem and nisoldipine (Bay k 5552), a new dihydropyridine calcium antagonist. , 1981, The Journal of pharmacology and experimental therapeutics.

[30]  O. Bertel,et al.  Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure. , 1981, American heart journal.

[31]  H. Hecht,et al.  Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease. , 1981, The American journal of cardiology.

[32]  R. Balcon,et al.  Unpredictable response to nifedipine in severe cardiac failure. , 1980, British medical journal.

[33]  S. Matsumoto,et al.  Hemodynamic effects of nifedipine in congestive heart failure. , 1980, The American journal of cardiology.

[34]  R. Gorlin,et al.  Importance of left ventricular chamber size in determining the response to hydralazine in severe chronic heart failure. , 1980, The New England journal of medicine.

[35]  D. Gillmer,et al.  Pulmonary oedema precipitated by nifedipine. , 1980, British medical journal.

[36]  F. Camerini,et al.  Haemodynamic effects of nifedipine in heart failure. , 1980, British heart journal.

[37]  R. Towart,et al.  Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552). , 1980, Arzneimittel-Forschung.

[38]  I. Kopin,et al.  Hydrochlorothiazide‐induced sympathetic hyperactivity in hypertensive patients , 1979, Clinical pharmacology and therapeutics.

[39]  W L Ashburn,et al.  Reproducibility of ejection-fraction determinations by equilibrium radionuclide angiography in response to supine bicycle exercise: concise communication. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[40]  D R Ricci,et al.  Validity of left-ventricular ejection fractions measured at rest and peak exercise by equilibrium radionuclide angiography using short acquisition times. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[41]  M. Olivari,et al.  Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema. , 1979, The American journal of medicine.

[42]  Bramahn . Singh,et al.  Effects of intravenous verapamil on hemodynamics in patients with heart disease. , 1977, American heart journal.

[43]  J. Cohn,et al.  Vasodilator Therapy of Cardiac Failure , 1977 .

[44]  M. da Prada,et al.  Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. , 1976, Life sciences.

[45]  J. Laragh,et al.  The renin system: Variations in man measured by radioimmunoassay or bioassay. , 1972, Kidney international.

[46]  H. Burchell,et al.  Focal myocarditis associated with pheochromocytoma. , 1966, The New England journal of medicine.